After participating in this program GPs will gain a better understanding of people living with type 2 diabetes mellitus who have an increased risk for the development of cardiac and other vascular events, heart failure (HF), and decline in renal function.
This interactive online learning activity is valued at 1 Hour(s) of continuing education.
MBBS (Hons) FRACGP
Macleay St Medical Practice
Potts Point, Sydney, NSW
Professor Andrew Sindone
B. Med (Hons), MD, FRACP, FCSNZ
Clinical Associate Professor, Sydney University
Adjunct Professor, University of Western Sydney
Director Heart Failure Unit and Department of
Cardiac Rehabilitation, Concord Hospital
Consultant Cardiologist, Ryde Hospital, NSW
On completion of this program, participants will be better able to:
- Demonstrate knowledge of latest guideline recommendations and key clinical trial findings regarding selection of glucose lowering medications in patients with atherosclerotic cardiovascular disease (ASCVD).
- Apply knowledge of the cardiovascular outcomes associated with newer hypoglycaemic agents to treatment selection in clinical practice.
- Individualise diabetes treatment protocols based on patients’ risk profiles and comorbidities.